Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Horrevorts SK"'
Autor:
van Wigcheren GF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands; Oncode Institute, The Netherlands., Cuenca-Escalona J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Stelloo S; Oncode Institute, The Netherlands; Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands., Brake J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Peeters E; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Horrevorts SK; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Frölich S; Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands., Ramos-Tomillero I; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Wesseling-Rozendaal Y; Philips Research, Eindhoven, The Netherlands., van Herpen CML; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands., van de Stolpe A; Philips Research, Eindhoven, The Netherlands., Vermeulen M; Oncode Institute, The Netherlands; Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands., de Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands. Electronic address: jolanda.devries@radboudumc.nl., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands; Oncode Institute, The Netherlands., Flórez-Grau G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2023 Nov; Vol. 299 (11), pp. 105276. Date of Electronic Publication: 2023 Sep 20.
Autor:
Van Wigcheren GF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., De Haas N; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Mulder TA; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Horrevorts SK; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Bloemendal M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands., Hins-Debree S; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Mao Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Kiessling R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., van Herpen CML; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands., Flórez-Grau G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., Hato SV; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands., De Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2021 Jun 27; Vol. 10 (1), pp. 1935557. Date of Electronic Publication: 2021 Jun 27 (Print Publication: 2021).
Palmitoylated antigens for the induction of anti-tumor CD8 + T cells and enhanced tumor recognition.
Autor:
Stolk DA; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., Horrevorts SK; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., Schetters STT; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., Kruijssen LJW; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., Duinkerken S; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., Keuning E; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., Ambrosini M; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., Kalay H; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., van de Ven R; Amsterdam UMC, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.; Amsterdam UMC, Department of Otolaryngology/Head and Neck Surgery, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., Garcia-Vallejo JJ; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., de Gruijl TD; Amsterdam UMC, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., van Vliet SJ; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands., van Kooyk Y; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
Publikováno v:
Molecular therapy oncolytics [Mol Ther Oncolytics] 2021 Apr 29; Vol. 21, pp. 315-328. Date of Electronic Publication: 2021 Apr 29 (Print Publication: 2021).
Autor:
Horrevorts SK; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Stolk DA; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., van de Ven R; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.; Department of Otolaryngology/Head and Neck Surgery, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Hulst M; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., van Het Hof B; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Duinkerken S; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Heineke MH; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Ma W; Ludwig Institute for Cancer Research, B-1200 Brussels, Belgium.; Walloon Excellence in Life Sciences and Biotechnology, B-1200 Brussels, Belgium.; De Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium., Dusoswa SA; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Nieuwland R; Laboratory of Experimental Clinical Chemistry, and Vesicle Observation Centre, Amsterdam UMC, Academic Medical Centre, 1081 HV Amsterdam, The Netherlands., Garcia-Vallejo JJ; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., van de Loosdrecht AA; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., de Gruijl TD; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., van Vliet SJ; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., van Kooyk Y; Department of Molecular Cell Biology and Immunology, Amsterdam Infection and Immunity Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands. y.vankooyk@amsterdamumc.nl.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Aug 28; Vol. 11 (9). Date of Electronic Publication: 2019 Aug 28.
Autor:
Duinkerken S; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Horrevorts SK; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Kalay H; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Ambrosini M; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Rutte L; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., de Gruijl TD; Amsterdam UMC, Department of Medical Oncology, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Garcia-Vallejo JJ; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., van Kooyk Y; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Publikováno v:
Theranostics [Theranostics] 2019 Aug 12; Vol. 9 (20), pp. 5797-5809. Date of Electronic Publication: 2019 Aug 12 (Print Publication: 2019).
Autor:
Dusoswa SA; Department of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Horrevorts SK; Department of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Ambrosini M; Department of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Kalay H; Department of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Paauw NJ; Department of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Nieuwland R; Laboratory of Experimental Clinical Chemistry, and Vesicle Observation Centre, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Pegtel MD; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Würdinger T; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Van Kooyk Y; Department of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Garcia-Vallejo JJ; Department of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Journal of extracellular vesicles [J Extracell Vesicles] 2019 Aug 09; Vol. 8 (1), pp. 1648995. Date of Electronic Publication: 2019 Aug 09 (Print Publication: 2019).
Autor:
Schetters STT; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Jong WSP; Abera Bioscience AB, Stockholm, Sweden., Horrevorts SK; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Kruijssen LJW; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Engels S; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Stolk D; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Daleke-Schermerhorn MH; Abera Bioscience AB, Stockholm, Sweden; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Science, VU University, Amsterdam, The Netherlands., Garcia-Vallejo J; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Houben D; Abera Bioscience AB, Stockholm, Sweden; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Science, VU University, Amsterdam, The Netherlands., Unger WWJ; Laboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., den Haan JMM; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Luirink J; Abera Bioscience AB, Stockholm, Sweden; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Science, VU University, Amsterdam, The Netherlands., van Kooyk Y; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands. Electronic address: y.vankooyk@vumc.nl.
Publikováno v:
Acta biomaterialia [Acta Biomater] 2019 Jun; Vol. 91, pp. 248-257. Date of Electronic Publication: 2019 Apr 17.
Autor:
Horrevorts SK; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands., Duinkerken S; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands., Bloem K; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands.; Centre for Specialized Nutrition, Danone Research, Wageningen, Netherlands., Secades P; Division of Cell Biology, Dutch Cancer Institute, Amsterdam, Netherlands., Kalay H; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands., Musters RJ; Department of Physiology, VU University Medical Center, Amsterdam, Netherlands., van Vliet SJ; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands., García-Vallejo JJ; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands., van Kooyk Y; Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands.
Publikováno v:
Frontiers in immunology [Front Immunol] 2018 Jun 14; Vol. 9, pp. 1231. Date of Electronic Publication: 2018 Jun 14 (Print Publication: 2018).
Autor:
Horrevorts SK; Department of Molecular Cell Biology & Immunology, VU University Medical Center, Amsterdam, The Netherlands., Garcia-Vallejo JJ; Department of Molecular Cell Biology & Immunology, VU University Medical Center, Amsterdam, The Netherlands., van Vliet SJ; Department of Molecular Cell Biology & Immunology, VU University Medical Center, Amsterdam, The Netherlands., van de Loosdrecht AA; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., van Kooyk Y; Department of Molecular Cell Biology & Immunology, VU University Medical Center, Amsterdam, The Netherlands., de Gruijl TD; Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Immunotherapy [Immunotherapy] 2016; Vol. 8 (1), pp. 5-8. Date of Electronic Publication: 2015 Dec 07.